• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Enzymotec Ltd

+ Add to Watchlist

ENZY:US

7.4430 USD 0.3170 4.09%

As of 12:02:56 ET on 12/22/2014.

Snapshot for Enzymotec Ltd (ENZY)

Open: 7.3800 Day's Range: 7.3100 - 7.7000 Volume: 13,177
Previous Close: 7.7600 52wk Range: 6.3400 - 30.7800 1-Yr Rtn: -74.85%

Stock Chart for ENZY

No chart data available.
  • ENZY:US 7.4430
  • 1D
  • 1M
  • 1Y
7.7600
Interactive ENZY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ENZY

Current P/E Ratio (ttm) 16.9318
Estimated P/E(12/2014) 19.6053
Relative P/E vs. SPX 0.9232
Earnings Per Share (USD) (ttm) 0.4400
Est. EPS (USD) (12/2014) 0.3800
Est. PEG Ratio 1.1522
Market Cap (M USD) 161.80
Shares Outstanding (M) 21.72
30 Day Average Volume 46,651
Price/Book (mrq) 1.2809
Price/Sale (ttm) 2.9411
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ENZY

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ENZY

Enzymotec Ltd. produces specialty chemicals. The Company develops and manufactures nutritional ingredients and medical foods. Enzymotec operates in both the nutrition and pharmaceutical markets and has a diverse range of products that spans the human life cycle, from infancy to adulthood.

Steve DubinChairmanYoav DoppeltVice Chairman
Ariel KatzPresident/CEO/Head:Vaya PharmaYoni TwitoChief Operations Officer
More Company Profile & Key Executives for ENZY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil